Triple combination therapy shows promise against a rare, deadly asbestos cancer

Combining immune-boosting drugs with radiation and surgery increased the survival and anticancer immune response in mouse models of mesothelioma in preclinical research by Princess Margaret Cancer Centre researchers. In a series of exciting experiments using mouse models of mesothelioma cancer, researchers found that combining two immunotherapy drugs can amplify the anti-tumor response first triggered by a short course of radiation, […]
» Read more